Construction of a machine learning-based screening model for IgD myeloma
Clinica Chimica Acta · 2025-09 · 577 · 120488
DOI: 10.1016/j.cca.2025.120488 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinica Chimica Acta, 2025-09. Verfasst von Manli Zhou und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008 Hunan, China. Hauptthemen laut MEDLINE: Multiple Myeloma, Immunoglobulin D, Machine Learning. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Key Research and Development Program of Hunan Province of China, Hunan Provincial Natural Science Foundation, Xiangya Hospital, Central South University.
Abstract (Originalsprache)
OBJECTIVE: Immunoglobulin D (IgD) myeloma is a rare subtype of multiple myeloma (MM), comprising approximately 1 %-2 % of all MM cases. Owing to the diminished levels of IgD in serum, IgD MM manifests as subtle M protein spikes in routine serum electrophoresis, rendering it susceptible to misdiagnosis and underdiagnosis. The objective of this study was to develop a machine learning (ML) model utilizing readily available complete blood count and biochemical test data for the purpose of screening IgD MM. METHODS: This study encompassed clinical data from 83 newly diagnosed IgD MM patients and 166 non-IgD MM patients, decision tree, random forest, support vector machine (SVM), stochastic gradient descent (SGD), and adaptive boosting (AdaBoost) algorithms were employed for model construction. The predictive performance of the ML models was evaluated using the area under the receiver operating characteristic curve (AUC), calibration curve analysis, and decision curve analysis. RESULTS: The random forest-based screening model demonstrated superior performance, incorporating seven key features: LDH, albumin, creatinine, Ca, β2 microglobulin, age and Hb. It achieved an AUC of 0.954 (95 % CI 0.930-0.977), with a sensitivity of 0.958, specificity of 0.747, positive predictive value of 88.3 % and negative predictive value of 89.9 %. Furthermore, this model has been evaluated in the validation cohort. CONCLUSIONS: The model constructed based on the random forest algorithm demonstrates potential in screening IgD MM patients, particularly when routine IgD immunotyping testing is not conducted in clinical practice. This can assist clinicians in early diagnosis and personalized treatment strategies, thereby optimizing the utilization of medical resources.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008 Hunan, China.
- Department of Clinical Laboratory, Xiangya Hospital, Central South University, Changsha 410008 Hunan, China; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsh…
Förderung
- Key Research and Development Program of Hunan Province of China
- Hunan Provincial Natural Science Foundation
- Xiangya Hospital, Central South University
- Central South University
Zitieren
APA
Zhou, M., & Feng, S. (2025). Construction of a machine learning-based screening model for IgD myeloma. Clinica Chimica Acta, 577, 120488. https://doi.org/10.1016/j.cca.2025.120488
Vancouver
Zhou M, Feng S. Construction of a machine learning-based screening model for IgD myeloma. Clinica Chimica Acta. 2025;577:120488. doi:10.1016/j.cca.2025.120488
BibTeX
@article{Zhou2025,
author = {Zhou, Manli and Feng, Sisi},
title = {Construction of a machine learning-based screening model for IgD myeloma},
journal = {Clinica Chimica Acta},
year = {2025},
volume = {577},
pages = {120488},
doi = {10.1016/j.cca.2025.120488}
}
EUVIMED